A randomised, double-blind, placebo-controlled, cross-over pilot study using nabilone for symptomatic relief in patients with Huntington's disease
Completed
- Conditions
- Huntington's diseaseNervous System Diseases
- Registration Number
- ISRCTN16782845
- Lead Sponsor
- Birmingham and Solihull Mental Health Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Competent patients with a clinical diagnosis of Huntington's disease over 18
Exclusion Criteria
1. Under 18
2. Known allergy to cannabinoids
3. Liver dysfunction
4. Personal or family history of psychosis
5. Heart disease or hypertension
6. Pregnant or lactating
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Motor symptoms rated using the motor scale from the UHDRS
- Secondary Outcome Measures
Name Time Method Psychiatric symptoms rated using the behavioural assessment of the UHDRS and the NPI